Imaging in early tuberculosis

Robert Wilkinson
DOI: https://doi.org/10.1136/thorax-2024-221993
2024-11-18
Thorax
Abstract:Tuberculosis (TB) is a pressing global human health problem that resulted in over 10 million cases and 1.3 million deaths in 2022.1 The WHO proposes to end this global epidemic by 2035, which would necessitate reducing TB deaths by 95%, TB incidence by 90%, and eliminating catastrophic costs for TB-affected households compared with the 2015 levels. There is doubt this can be achieved. An established means to attempt these reductions would be greater yet more targeted use of preventive antibiotic therapy for clinically asymptomatic (referred to as latent) early or limited infection. A recent systematic review estimated the overall effectiveness of preventive treatment (TPT) is 49%.2 The risk reduction conferred by TPT was found greater in high-burden (0.31) versus low-burden (0.58) settings. Most studies covered by the analysis deployed established TPT regimens of 6–9 months isoniazid (H), 4 months of rifampicin (R) or 3 months of combined...
respiratory system
What problem does this paper attempt to address?